We are live on ! Find out more
NICM

Neo Ivy Capital Management Portfolio holdings

AUM $379M
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
+18.75%
1 Year Est. Return
+28.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$87.2M
AUM Growth
+$25.8M
Cap. Flow
+$18.4M
Cap. Flow %
21.14%
Top 10 Hldgs %
9.07%
Holding
666
New
217
Increased
117
Reduced
105
Closed
226

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$883K
2
LHX icon
L3Harris
LHX
+$877K
3
JNJ icon
Johnson & Johnson
JNJ
+$836K
4
INTC icon
Intel
INTC
+$803K
5
PRU icon
Prudential Financial
PRU
+$759K

Top Sells

Rank Stock Value
1
ETR icon
Entergy
ETR
+$563K
2
COST icon
Costco
COST
+$557K
3
CTAS icon
Cintas
CTAS
+$506K
4
TMO icon
Thermo Fisher Scientific
TMO
+$503K
5
ALK icon
Alaska Air
ALK
+$476K

Sector Composition

Rank Sector Weight
1 Technology 17.61%
2 Financials 17.3%
3 Industrials 15.25%
4 Healthcare 15.11%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QVCGA
251
DELISTED
QVC Group Inc Series A
QVCGA
$97K 0.11%
+211
New +$82.4K
CI icon
252
Cigna
CI
$71.9B
$95K 0.11%
+508
New +$96.4K
NVTA
253
DELISTED
Invitae Corporation
NVTA
$95K 0.11%
+3,135
New +$54.7K
AVNT icon
254
Avient
AVNT
$4.16B
$94K 0.11%
+3,567
New +$82.8K
HE icon
255
Hawaiian Electric Industries
HE
$2.05B
$94K 0.11%
+2,619
New +$101K
TXN icon
256
Texas Instruments
TXN
$257B
$93K 0.11%
734
-2,108
-74% -$246K
CRI icon
257
Carter's
CRI
$1.46B
$91K 0.1%
1,132
+438
+63% +$34.9K
SEM
258
DELISTED
Select Medical
SEM
$91K 0.1%
11,403
-6,741
-37% -$55.8K
BYD icon
259
Boyd Gaming
BYD
$6.03B
$90K 0.1%
+4,308
New +$78.6K
LPSN icon
260
LivePerson
LPSN
$32.2M
$90K 0.1%
+145
New +$67.5K
MGM icon
261
MGM Resorts International
MGM
$11B
$90K 0.1%
5,351
-9,204
-63% -$149K
NOV icon
262
NOV
NOV
$7.45B
$90K 0.1%
7,375
+6,324
+602% +$77.7K
UAA icon
263
Under Armour
UAA
$2.32B
$89K 0.1%
9,100
-12,383
-58% -$118K
FTI icon
264
TechnipFMC
FTI
$29.3B
$88K 0.1%
+17,331
New +$101K
SPXL icon
265
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.23B
$88K 0.1%
2,100
– –
PXD
266
DELISTED
Pioneer Natural Resource Co.
PXD
$88K 0.1%
+900
New +$79.3K
NUVA
267
DELISTED
NuVasive, Inc.
NUVA
$87K 0.1%
1,571
+222
+16% +$12.8K
CDNS icon
268
Cadence Design Systems
CDNS
$90B
$86K 0.1%
+897
New +$75.1K
KSS icon
269
Kohl's
KSS
$2.1B
$86K 0.1%
4,134
-7,826
-65% -$151K
LPLA icon
270
LPL Financial
LPLA
$29.5B
$85K 0.1%
+1,085
New +$72.5K
NATI
271
DELISTED
National Instruments Corp
NATI
$85K 0.1%
+2,194
New +$82.9K
BRO icon
272
Brown & Brown
BRO
$24B
$84K 0.1%
2,053
-7,178
-78% -$277K
KBH icon
273
KB Home
KBH
$3.54B
$84K 0.1%
+2,740
New +$75.4K
RSG icon
274
Republic Services
RSG
$66.3B
$84K 0.1%
+1,025
New +$82.6K
SRE icon
275
Sempra
SRE
$55.4B
$82K 0.09%
+1,400
New +$86K
9 10
11
12 13

Similar funds

MC
Muhlenkamp & Co Wexford, Pennsylvania $380M AUM 43.74% 1-Year Est. Return
ACA
Anchorage Capital Advisors New York $378M AUM 13.47% 1-Year Est. Return
AFCM
Alta Fox Capital Management Fort Worth, Texas $378M AUM 59.19% 1-Year Est. Return
DAL
Delta Air Lines Atlanta, Georgia $378M AUM 12.68% 1-Year Est. Return
SFWC
Strategic Family Wealth Counselors Fairfield, New Jersey $381M AUM 21.36% 1-Year Est. Return
FP
Fivespan Partners San Francisco, California $377M AUM
C
Cliffwater Marina Del Rey, California $377M AUM 5.73% 1-Year Est. Return
HCP
Hiddenite Capital Partners New York $381M AUM 73.07% 1-Year Est. Return

Neo Ivy Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Neo Ivy Capital Management held 666 positions worth $87.2M, up 42% from $61.4M the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.

Neo Ivy Capital Management deployed $18.4M of net new capital in Q2 2020, opening 217 new positions and adding to 117 existing holdings. Its largest new stake was Pfizer: 26,000 shares worth $807K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Cintas, an estimated $506K trimmed.

  • Neo Ivy Capital Management's largest Q2 2020 buy was Pfizer: 26,000 shares worth $807K.
  • Neo Ivy Capital Management added most to CME Group in Q2 2020, an estimated $750K increase.
  • Neo Ivy Capital Management's biggest Q2 2020 reduction was Cintas, cutting an estimated $506K.
  • Neo Ivy Capital Management fully exited Entergy in Q2 2020, selling an estimated $563K.
  • Neo Ivy Capital Management's ten largest holdings make up 9.1% of its $87.2M portfolio in Q2 2020.
  • Neo Ivy Capital Management opened 217 new positions and closed 226 in Q2 2020.
  • Neo Ivy Capital Management's portfolio value rose 42% quarter-over-quarter to $87.2M.

Based on Neo Ivy Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.